Literature DB >> 29552448

Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon.

Francisco Galeano-Valle1,2, Pablo Demelo-Rodriguez1,2, Luís Álvarez-Sala-Walther2,3, Blanca Pinilla-Llorente2,3, Miguel Jesús Echenagusia-Boyra4, Hugo Rodriguez-Abella5, Jorge Del-Toro-Cervera1,3.   

Abstract

Behçet's Disease (BD) is a rare multi-systemic inflammatory disorder classified as a systemic vasculitis of unknown aetiology. Vascular involvement occurs in approximately 5-51.6% cases, affecting venous and arterial vessels. Cardiac involvement is rare in BD (6%). There have been published approximately 93 cases of BD associated with intracardiac thrombosis, with different treatments and courses. We present a case of a 35-year-old spanish male that, after a percutaneous pharmacomechanical thrombectomy with venous stent placement, developed high fever and extensive venous thrombosis despite anticoagulation including intracardiac thrombosis (ICT) in the right ventricle and pulmonary embolism that leaded to the diagnosis of BD. The patient was successfully treated with immunosuppressants, achieving the complete resolution of ICT. We hypotesize that the endovenous procedure could have acted as a trigger for the posterior acute attack of the disease, representing a 'vascular pathergy phenomenon'. Vascular BD has to be suspected in cases of thrombosis recurrence despite correct anticoagulation, and intense immunosuppressive treatment should be considered.

Entities:  

Keywords:  Behçet disease; immunosuppressive agents; intracardiac thrombus; thrombectomy; venous thromboembolism

Year:  2018        PMID: 29552448      PMCID: PMC5849627          DOI: 10.5582/irdr.2018.01006

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  18 in total

Review 1.  Intracardiac thrombus in Behçet's disease: a systematic review.

Authors:  N Mogulkoc; M I Burgess; P W Bishop
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Intracardiac thrombus in patients with Behcet's disease: clinical correlates, imaging features, and outcome: a retrospective, single-center experience.

Authors:  Hui Wang; Xiaoxiao Guo; Zhuang Tian; Yongtai Liu; Qian Wang; Mengtao Li; Xiaofeng Zeng; Quan Fang
Journal:  Clin Rheumatol       Date:  2016-01-11       Impact factor: 2.980

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Highlights of the 17th International Conference on Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi; Pietro Leccese; Ignazio Olivieri
Journal:  Clin Exp Rheumatol       Date:  2016-10-25       Impact factor: 4.473

Review 5.  Behçet's disease: How to diagnose and treat vascular involvement.

Authors:  Emire Seyahi
Journal:  Best Pract Res Clin Rheumatol       Date:  2016-09-16       Impact factor: 4.098

6.  A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients.

Authors:  Hakan Emmungil; N Şule Yaşar Bilge; Orhan Küçükşahin; Levent Kılıç; Sercan Okutucu; Sercan Gücenmez; Umut Kalyoncu; Timuçin Kaşifoğlu; Murat Turgay; Kenan Aksu
Journal:  Clin Exp Rheumatol       Date:  2014-07-28       Impact factor: 4.473

Review 7.  Major vessel involvement in Behçet's disease: an update.

Authors:  Kenneth T Calamia; Michael Schirmer; Melike Melikoglu
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

8.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

Authors: 
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-02-26       Impact factor: 6.166

9.  Major vascular involvement in Behçet's disease: a retrospective study of 796 patients.

Authors:  Yunyun Fei; Xuemei Li; Sen Lin; Xiaojun Song; Qingjun Wu; Yanlin Zhu; Xin Gao; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2013-02-27       Impact factor: 2.980

10.  Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.

Authors:  Joong Kyong Ahn; You Sun Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Clin Rheumatol       Date:  2007-07-17       Impact factor: 2.980

View more
  3 in total

1.  Budd-Chiari Syndrome in Behçet's Disease successfully managed with immunosuppressive and anticoagulant therapy: A case report and literature review.

Authors:  Christian Mario Amodeo Oblitas; Francisco Galeano-Valle; Neera Toledo-Samaniego; Blanca Pinilla-Llorente; Jorge Del Toro-Cervera; Arturo Álvarez-Luque; Alejandra García-García; Pablo Demelo-Rodriguez
Journal:  Intractable Rare Dis Res       Date:  2019-02

Review 2.  Arterial and venous involvement in Behçet's syndrome: a narrative review.

Authors:  Neera Toledo-Samaniego; Crhistian Mario Oblitas; Eduardo Peñaloza-Martínez; Jorge Del-Toro-Cervera; Luis Antonio Alvarez-Sala-Walther; Pablo Demelo-Rodríguez; Francisco Galeano-Valle
Journal:  J Thromb Thrombolysis       Date:  2022-02-19       Impact factor: 2.300

3.  Intracardiac thrombus in Behçet's disease: a rare case in Morocco.

Authors:  Younes Amchich; Nezha Reguig; Abdelhalim Boucaid; Reda Belghoule; Adil Zegmout; Jamal Eddine Bourkadi
Journal:  Pan Afr Med J       Date:  2020-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.